Divide & Conquer Competitors and Similar CompaniesClear all
Divide & Conquer's competitors and similar companies include Arch Oncology and Paradigm Diagnostics.
 Divide & Conquer Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy. |  Arch Oncology Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer. |  Paradigm Diagnostics Paradigm Diagnostics is a precision medicine company focused on comprehensive cancer testing. | |
Founding Date | Founding Date 2018 | Founding Date 2006 | Founding Date 2012 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Babraham, GB HQ | Locations Brisbane, US HQ St. Louis, US | Locations Phoenix, US HQ |
Employees | Employees 2 | Employees 7 | Employees 717% increase |
Funding | |||
Latest funding round | Latest funding round $ 12.5m (over 6 years ago) | Latest funding round $ 105m (about 5 years ago) | Latest funding round $ 15m (almost 7 years ago) |
Total funding raised | Total funding raised $ 12.5m | Total funding raised $ 155m | Total funding raised $ 23.9m |
For sources of this data, please see the company profile
View Company Profiles
Arch Oncology
HQ
Brisbane, US
Employees
7
Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer.
View companyParadigm Diagnostics
HQ
Phoenix, US
Employees
7↑ 17% increase
Paradigm Diagnostics is a precision medicine company focused on comprehensive cancer testing.
View company